English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  51314503    ???header.onlineuser??? :  850
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"potena l"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-7 of 7  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2020-03-05T08:37:44Z Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation Kobashigawa J.;Ross H.;Bara C.;Delgado J.F.;Dengler T.;Lehmkuhl H.B.;Shoei-Shen Wang;Dong G.;Witte S.;Junge G.;Potena L.; Kobashigawa J.; Ross H.; Bara C.; Delgado J.F.; Dengler T.; Lehmkuhl H.B.; SHOEI-SHEN WANG; Dong G.; Witte S.; Junge G.; Potena L.
臺大學術典藏 2020-03-05T08:37:43Z Everolimus immunosuppression in de novo heart transplant recipients: What does the evidence tell us now? Zuckermann A.; SHOEI-SHEN WANG; Epailly E.; Barten M.J.; Sigurdardottir V.; Segovia J.; Varnous S.; Turazza F.M.; Potena L.; Lehmkuhl H.B.
臺大學術典藏 2020-03-05T08:37:43Z Everolimus versus mycophenolate mofetil in heart transplantation: A randomized, multicenter trial Eisen H.J.;Kobashigawa J.;Starling R.C.;Pauly D.F.;Kfoury A.;Ross H.;Shoei-Shen Wang;Cantin B.;Van Bakel A.;Ewald G.;Hirt S.;Lehmkuhl H.;Keogh A.;Rinaldi M.;Potena L.;Zuckermann A.;Dong G.;Cornu-Artis C.;Lopez P.; Eisen H.J.; Kobashigawa J.; Starling R.C.; Pauly D.F.; Kfoury A.; Ross H.; SHOEI-SHEN WANG; Cantin B.; Van Bakel A.; Ewald G.; Hirt S.; Lehmkuhl H.; Keogh A.; Rinaldi M.; Potena L.; Zuckermann A.; Dong G.; Cornu-Artis C.; Lopez P.
臺大學術典藏 2018-09-10T09:52:17Z Everolimus immunosuppression in de novo heart transplant recipients: What does the evidence tell us now? Zuckermann, A.;Wang, S.-S.;Epailly, E.;Barten, M.J.;Sigurdardottir, V.;Segovia, J.;Varnous, S.;Turazza, F.M.;Potena, L.;Lehmkuhl, H.B.; Zuckermann, A.; Wang, S.-S.; Epailly, E.; Barten, M.J.; Sigurdardottir, V.; Segovia, J.; Varnous, S.; Turazza, F.M.; Potena, L.; Lehmkuhl, H.B.
臺大學術典藏 2018-09-10T09:52:17Z Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation Ross, H.; Bara, C.; Delgado, J.F.; Dengler, T.; Lehmkuhl, H.B.; Wang, S.-S.; Dong, G.; Witte, S.; Junge, G.; Potena, L.; Kobashigawa, J.
臺大學術典藏 2018-09-10T09:52:17Z Everolimus versus mycophenolate mofetil in heart transplantation: A randomized, multicenter trial Kobashigawa, J.; Starling, R.C.; Pauly, D.F.; Kfoury, A.; Ross, H.; Wang, S.-S.; Cantin, B.; Van Bakel, A.; Ewald, G.; Hirt, S.; Lehmkuhl, H.; Keogh, A.; Rinaldi, M.; Potena, L.; Zuckermann, A.; Dong, G.; Cornu-Artis, C.; Lopez, P.; Eisen, H.J.
國立臺灣大學 2013 Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation Kobashigawa, J.; Ross, H.; Bara, C.; Delgado, J. F.; Dengler, T.; Lehmkuhl, H. B.; Wang, S. -S.; Dong, G.; Witte, S.; Junge, G.; Potena, L.; 王水深

Showing items 1-7 of 7  (1 Page(s) Totally)
1 
View [10|25|50] records per page